Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2025-04-04 | Ms. Norwalk has served as Strategic Counsel at Epstein Becker & Green, P.C. since 2007 ... She serves on the boards of Arvinas, Inc., ModivCare Inc., Neurocrine Biosciences, Inc. and Globus Medical, Inc. ... Ms. Norwalk was appointed to the Health Services and Technology Committee in November 2024. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-06-14 | Ms. Norwalk’s significant healthcare regulatory and policy expertise, including her experiences with the Bush Administration on Medicare and Medicaid matters, provides needed industry expertise to the Board. |
| 2017-04-28 | Ms. Norwalk has served as Strategic Counsel to Epstein Becker & Green, P.C.... She received a bachelor's degree from Wellesley College and a juris doctor degree from George Mason University School of Law. Ms. Norwalk’s significant healthcare regulatory and policy expertise provides needed healthcare industry expertise to the Board. |
| 2018-04-27 | She received a bachelor's degree from Wellesley College and a juris doctor degree from George Mason University School of Law. |
| 2019-04-26 | Ms. Norwalk received a bachelor's degree from Wellesley College and a juris doctor degree from George Mason University School of Law. |
| 2020-04-29 | Ms. Norwalk practiced law with Epstein Becker & Green, P.C... She received a bachelor's degree from Wellesley College and a juris doctor degree from George Mason University School of Law. |
| 2021-04-30 | Ms. Norwalk served in the Centers for Medicare & Medicaid Services and has a juris doctor degree from George Mason University School of Law. |
| 2023-05-01 | She received a bachelor's degree from Wellesley College and a juris doctor degree from George Mason University School of Law. Ms. Norwalk’s significant healthcare regulatory and policy expertise, including her experiences with the Bush Administration on Medicare and Medicaid matters, provides healthcare industry expertise to the Board. |
| 2024-04-29 | Since September 2007, Ms. Norwalk has served as Strategic Counsel to Epstein Becker & Green, P.C. From 2001 to 2007, Ms. Norwalk served the Bush Administration in the Centers for Medicare & Medicaid Services (CMS). From 2006 to 2007, she was the Acting Administrator, where she managed the operations of federal health care programs, including Medicare and Medicaid. For the four years prior to that position, she was the agency’s Deputy Administrator. Prior to serving the Bush Administration, Ms. Norwalk practiced law with Epstein Becker & Green, P.C. where she advised clients on a variety of healthcare policy matters. She also served the first Bush administration in the White House Office of Presidential Personnel and the Office of the U.S. Trade Representative. Ms. Norwalk is currently a director on the public company boards of NuVasive Inc., a medical device company, Neurocrine Biosciences, Inc., a biopharmaceutical company, and Arvinas Inc., a clinical-stage biopharmaceutical company. She also serves as an Advisor to several private equity funds. She received a bachelor's degree from Wellesley College and a juris doctor degree from George Mason University School of Law. |
| 2025-02-03 | Leslie V. Norwalk 18,830 * |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-09 | Leslie V. Norwalk has served on the Board of Directors since September 2019. ... Ms. Norwalk is an Operating Partner at Enhanced Equity Fund, L.P., a private equity firm, and also serves as an advisor to Warburg Pincus LLC, and Peloton Equity, both private equity firms. ... Ms. Norwalk holds a Juris Doctorate from the George Mason University School of Law and a Bachelor of Arts degree in economics and international relations from Wellesley College. |
| 2021-04-09 | Leslie V. Norwalk has served on the Board of Directors since September 2019. The Nominating/Corporate Governance Committee consists of directors Stephen A. Sherwin, M.D., George J. Morrow and Leslie V. Norwalk. For 2020, directors who are not employees of the Company earned a $55,000 annual cash retainer. Each other director who was a member of the Nominating/Corporate Governance Committee earned an additional annual cash retainer of $5,000. Additionally, for 2020, each non-employee director received a grant of a nonstatutory stock option to purchase 6,018 shares of the Companys common stock, representing an approximate value of $400,000 on the date of the 2020 Annual Meeting of Stockholders. The following table sets forth the compensation earned for the fiscal year ended December 31, 2020 by the directors of the Company named below: Leslie V. Norwalk Fees Earned or Paid in Cash $63,628 Option Awards $400,030 Total $463,658. |
| 2022-04-07 | Leslie V. Norwalk has served on the Board of Directors since September 2019. ... The Company’s Nominating/Corporate Governance Committee consists of directors Stephen A. Sherwin, M.D., Johanna Mercier, George J. Morrow, and Leslie V. Norwalk, with Ms. Norwalk serving as the Nominating/Corporate Governance Committee Chair. ... For 2021, directors who are not employees of the Company earned a $60,000 annual cash retainer. ... The following table sets forth the compensation earned for the fiscal year ended December 31, 2021 by the directors of the Company named below: Leslie V. Norwalk $75,000 fees earned in cash and $400,003 option awards totaling $475,003. |
| 2023-04-05 | Leslie V. Norwalk has served on the Board of Directors since September 2019. Since 2007, Ms. Norwalk has served as Strategic Counsel to healthcare companies at Epstein Becker Green, EBG Advisors and National Health Advisors. Ms. Norwalk advises several private equity firms on healthcare matters. She serves as a director of NuVasive, Inc., Modivcare, and Arvinas, Inc., all publicly traded companies, as well as several privately held healthcare companies. Ms. Norwalk previously served on the Board of Directors of Centene, Endologix, Magellan Health, and Press Ganey. Ms. Norwalk began her career in the public sector as The White House Special Assistant to the Office of Presidential Personnel under the first Bush administration, following which, she practiced law at the Washington, D.C. office of Epstein Becker Green, P.C. From 2001 to 2007 she served in several roles at the Centers for Medicare & Medicaid Services (CMS) under the George W. Bush administration, including serving as Deputy Administrator, and Counselor and Policy Advisor, before assuming the role of Acting Administrator. Ms. Norwalk holds a J.D. from the George Mason University School of Law and a B.A. in Economics and International Relations from Wellesley College. The Company’s Nominating/Corporate Governance Committee consists of directors Stephen A. Sherwin, M.D., Johanna Mercier, George J. Morrow, and Leslie V. Norwalk, with Ms. Norwalk serving as the Nominating/Corporate Governance Committee Chair. |
| 2024-04-10 | Leslie V. Norwalk has served on the Board of Directors since September 2019. ... Ms. Norwalk advises several private equity firms on healthcare matters. She serves as a director of Globus Medical, Inc., Modivcare Inc., and Arvinas, Inc., all publicly traded companies, as well as several privately held healthcare companies. ... Ms. Norwalk previously served on the Board of Directors of Centene, Endologix, Magellan Health, NuVasive, Inc., prior to its acquisition by Globus Medical, and Press Ganey. ... Ms. Norwalk began her career in the public sector in The White House Office of Presidential Personnel under the first Bush administration, following which, she practiced law at the Washington, D.C. office of Epstein Becker Green, P.C. From 2001 to 2007, she served in several roles at the Centers for Medicare & Medicaid Services (CMS) under the George W. Bush administration, including serving as Deputy Administrator, and Counselor and Policy Advisor, before assuming the role of Acting Administrator. ... The Company’s Nominating / Corporate Governance Committee is responsible for recommending nominees for election to the Board of Directors, succession planning, developing and implementing policies and practices relating to corporate governance, and providing oversight with respect to the following matters: sustainability matters, supply chain risk, quality systems and drug safety. ... During 2023, the Company’s Nominating / Corporate Governance Committee consisted of directors Johanna Mercier, George J. Morrow, and Leslie V. Norwalk, and Stephen A. Sherwin, M.D., with Ms. Norwalk serving as the Nominating / Corporate Governance Committee Chair. ... For fiscal 2023, directors who are not employees of the Company earned a $60,000 annual cash retainer. ... For fiscal 2023, on the date of the 2023 Annual Meeting of Stockholders, each continuing non-employee director received an annual equity award with an approximate grant date value of $400,000. ... The following table sets forth the compensation earned for the fiscal year ended December 31, 2023 by the directors of the Company named below: ... Leslie V. Norwalk $75,000 cash fees, $200,067 option awards, $200,043 stock awards, total $475,110. |
Data sourced from SEC filings. Last updated: 2026-02-03